Cognitive Functional Therapy for Treating Individuals With Chronic Shoulder Pain
Launched by FEDERAL UNIVERSITY OF PARAÍBA · Oct 25, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called Cognitive Functional Therapy (CFT) for people suffering from chronic shoulder pain. Chronic shoulder pain can significantly affect daily life, both physically and mentally. The trial aims to see how CFT compares to traditional therapeutic exercise in helping reduce pain, improve function, and enhance overall well-being. Researchers believe that CFT, which takes into account both the physical and mental aspects of pain, may provide better results than exercise alone.
To participate in this study, you need to be between 18 and 60 years old and have had shoulder pain for more than three months, with a pain level of at least 4 on a scale from 0 to 10. The trial is open to all genders. Participants can expect to engage in either CFT or therapeutic exercise and will be monitored for improvements in pain, disability, sleep quality, and overall quality of life. It's important to note that certain conditions or recent treatments may exclude individuals from joining the trial, such as a history of shoulder surgery or certain diseases. If you're curious about whether you qualify or want to learn more, consider discussing it with your healthcare provider.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Men or women;
- • Age between 18 and 60 years;
- • Presence of shoulder pain for more than 3 months;
- • Pain intensity of 4 points or more on the 11-point Numeric Pain Rating Scale.
- • High level of disability or moderate level of irritability.
- Exclusion Criteria:
- • History of fracture or surgery of the clavicle, scapula, and/or humerus, surgical stabilization or rotator cuff repair;
- • History of dislocation, instability (positive sulcus sign or apprehension test), and/or rotator cuff tear (positive drop arm test);
- • Adhesive capsulitis verified by the presence of gradual onset pain associated with stiffness and reduced passive and active mobility;
- • Ongoing pregnancy;
- • Reproduction of shoulder pain radiating to the entire upper limb during cervical or thoracic spine tests (positive Spurling test);
- • Neurological or systemic diseases that may alter muscle strength and sensitivity such as rheumatoid arthritis, fibromyalgia, lupus, gout, and diabetes;
- • Corticosteroid injection in the shoulder region in the last 3 months;
- • Physiotherapy treatment in the last 6 months.
- • Active treatment for cancer
About Federal University Of Paraíba
The Federal University of Paraíba (UFPB) is a renowned academic institution located in Brazil, dedicated to advancing education, research, and innovation in various fields, including health sciences. With a commitment to excellence, UFPB actively engages in clinical trials aimed at contributing to medical knowledge and improving patient care. The university's research initiatives are supported by a multidisciplinary team of experts who collaborate to ensure rigorous ethical standards and scientific validity in their studies. UFPB's clinical trials focus on addressing pressing health challenges, fostering partnerships within the scientific community, and translating research findings into practical applications for the benefit of society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
João Pessoa, Paraíba, Brazil
João Pessoa, , Brazil
Patients applied
Trial Officials
Danilo H Kamonseki, PhD
Principal Investigator
Universidade Federal da Paraíba
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported